CD40LG and COVID-19: Among those, using an internally developed ELISA with recombinant SARS-CoV-2 NP antigen, Guo and colleagues recently showed that IgM antibodies were detectable in 85% of COVID-19-confirmed patients 1 to 7 days PSO (7).